Cargando…
Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
Chronic respiratory otorhinolaryngological (ORL) diseases may exacerbate. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776168/ https://www.ncbi.nlm.nih.gov/pubmed/31292425 http://dx.doi.org/10.23750/abm.v90i7-S.8656 |
_version_ | 1783456374689103872 |
---|---|
author | Gian, Franco Cupido Matteo, Gelardi Ignazio, La Mantia Salvo, Emanuele Aragona Claudio, Vicini Giorgio, Ciprandi |
author_facet | Gian, Franco Cupido Matteo, Gelardi Ignazio, La Mantia Salvo, Emanuele Aragona Claudio, Vicini Giorgio, Ciprandi |
author_sort | Gian, Franco Cupido |
collection | PubMed |
description | Chronic respiratory otorhinolaryngological (ORL) diseases may exacerbate. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity. The current survey, conducted in clinical practice of 84 Italian ORL centers, evaluated its safety and efficacy in the treatment of patients with exacerbated chronic upper airways disease. The 459 (254 males, mean age 44.7 years) patients were evaluated at baseline (T0) and after a 2-week treatment (T1), treated or not-treated with Broncalt®. Signs and symptoms severity were measured by visual analogue scale. Broncalt® significantly, quickly, and safely diminished the clinical features in all sub-groups (p<0.001 for all). In conclusion, Broncalt® is a class II Medical Device able to exert a safe, quick, and effective activity in patients with relapsed chronic ORL disorders. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-6776168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-67761682019-12-17 Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice Gian, Franco Cupido Matteo, Gelardi Ignazio, La Mantia Salvo, Emanuele Aragona Claudio, Vicini Giorgio, Ciprandi Acta Biomed Original Article Chronic respiratory otorhinolaryngological (ORL) diseases may exacerbate. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity. The current survey, conducted in clinical practice of 84 Italian ORL centers, evaluated its safety and efficacy in the treatment of patients with exacerbated chronic upper airways disease. The 459 (254 males, mean age 44.7 years) patients were evaluated at baseline (T0) and after a 2-week treatment (T1), treated or not-treated with Broncalt®. Signs and symptoms severity were measured by visual analogue scale. Broncalt® significantly, quickly, and safely diminished the clinical features in all sub-groups (p<0.001 for all). In conclusion, Broncalt® is a class II Medical Device able to exert a safe, quick, and effective activity in patients with relapsed chronic ORL disorders. (www.actabiomedica.it) Mattioli 1885 2019 2019-12-09 /pmc/articles/PMC6776168/ /pubmed/31292425 http://dx.doi.org/10.23750/abm.v90i7-S.8656 Text en Copyright: © 2019 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article Gian, Franco Cupido Matteo, Gelardi Ignazio, La Mantia Salvo, Emanuele Aragona Claudio, Vicini Giorgio, Ciprandi Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice |
title | Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice |
title_full | Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice |
title_fullStr | Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice |
title_full_unstemmed | Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice |
title_short | Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice |
title_sort | broncalt®, class ii medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776168/ https://www.ncbi.nlm.nih.gov/pubmed/31292425 http://dx.doi.org/10.23750/abm.v90i7-S.8656 |
work_keys_str_mv | AT gianfrancocupido broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice AT matteogelardi broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice AT ignaziolamantia broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice AT salvoemanuelearagona broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice AT claudiovicini broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice AT giorgiociprandi broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice |